Jincaopian Tablets
Chronic Pelvic Pain
Beijing Konruns Pharmaceutical Co., Ltd.Phase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 89/ 100
Competitive context
100 Active assets in the Chronic Pelvic Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-TRAMADOL EMS | Phase 4 | BBB |
METHADONE Cari Health Inc. | Phase 4 | BBB |
LIDOCAINE National and Kapodistrian University of Athens | Phase 4 | BBB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Stanford University | Phase 4 | BBB |
FENTANYL Aga Khan University | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →